Insights

Insights From Our Experts

Articles

Audit From Anywhere: Upgrade Your Quality System Audit Programs

As the world strives every day to adapt to changes this year, one change that pharma manufacturers are adapting to is the impact of COVID-19 on product safety audits. From supplier audits to evaluating internal or affiliated sites with…

Learning How to Play Dilution Dodgeball

The healthcare industry is reaching new heights in innovation, and as new drugs are founded, owners of biotech companies must decide whether or not they want to independently bring their product to market.  Developing and successfully commercializing a…

WODC Online 2021: Commercializing Advanced Therapies for Rare Diseases

Innovative rare disease therapies deserve innovative commercialization strategies.  With over 1,200 attendees from across the globe, the World Orphan Drug Congress featured one full day of virtual panels and presentations dedicated to drug development and commercialization.…

Visualizing EVERSANA’s Omnichannel Activation Model

The pharma industry’s needs have evolved beyond one-dimensional playbooks, disconnected promotional efforts and limited ability to assess stakeholder engagement.  Manufacturers need to adopt an omnichannel model that goes beyond “marketing” to provide actionable insights that better…

Pharmaceutical Opportunities and Challenges Facing Long-Term Care Facilities

Skilled nursing facilities (SNF) and long-term care (LTC) facilities have been a major source for news stories throughout the COVID-19 pandemic due to the devastation brought to patient populations. Now, pharmaceutical manufacturers have an opportunity to…

Ask the Expert: How to Maximize Your Omnichannel Strategy

Omnichannel strategies are transforming the way consumers interact with brands across industries – from the all-in-one Magic Band experience at Disney to buying your favorite latte with the Starbucks app. The pharmaceutical industry is no exception,…

Webinar: Under Pressure: Global Trends in Net Price

In the past few years, net price transparency has become a subject of debate in the international pharma community. As pricing reforms and shifting pressures on pricing systems continue to intensify, how will they impact markets…

Expect More From Your Omnichannel Strategy and Investments

From ordering your daily Starbucks latte on your iPhone to skipping the line at Splash Mountain with your Disney Magic Band, omnichannel strategies transform how consumers interact with their favorite brands. The most successful brands create…

Five Trends That Will Shape the Current and Future Payer Market Landscape

As leading payers build new business models to ultimately advance their approaches to care and drug management, biopharmaceutical companies need to adjust their account engagement and drug access strategies accordingly. Here are a the top five…

Escaping the Chronic Microcap Trap: How Launching Alone Is the Only Option for Growth

As C-suite leaders in pharma wrestle with the pros and cons of launching alone, licensing or partnering with another company to launch their product, one factor they must consider is the impact their decision will have…